US HB3772 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 17-8)
Status: Introduced on July 16 2019 - 25% progression, died in committee
Action: 2019-07-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 16 2019 - 25% progression, died in committee
Action: 2019-07-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.
Title
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Sponsors
Rep. Scott Peters [D-CA] | Rep. Bobby Rush [D-IL] | Rep. George Holding [R-NC] | Rep. Ted Lieu [D-CA] |
Rep. James McGovern [D-MA] | Rep. Tim Burchett [R-TN] | Rep. David Loebsack [D-IA] | Rep. Darren Soto [D-FL] |
Rep. Elissa Slotkin [D-MI] | Rep. Seth Moulton [D-MA] | Rep. Harley Rouda [D-CA] | Rep. Dean Phillips [D-MN] |
Rep. Raja Krishnamoorthi [D-IL] | Rep. Bonnie Coleman [D-NJ] | Rep. Susan Brooks [R-IN] | Rep. Alan Lowenthal [D-CA] |
Rep. John Rutherford [R-FL] | Rep. Terri Sewell [D-AL] | Rep. Greg Murphy [R-NC] | Rep. Ann Kuster [D-NH] |
Rep. Jackie Walorski [R-IN] | Rep. Lisa Rochester [D-DE] | Rep. Bill Posey [R-FL] | Rep. Guy Reschenthaler [R-PA] |
Rep. Donald Payne [D-NJ] |
History
Date | Chamber | Action |
---|---|---|
2019-07-17 | House | Referred to the Subcommittee on Health. |
2019-07-16 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-07-16 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-07-16 | House | Introduced in House |
Subjects
Drug therapy
Health
Health care costs and insurance
Health technology, devices, supplies
Home and outpatient care
Medical tests and diagnostic methods
Medicare
Health
Health care costs and insurance
Health technology, devices, supplies
Home and outpatient care
Medical tests and diagnostic methods
Medicare
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/3772/all-info |
Text | https://www.congress.gov/116/bills/hr3772/BILLS-116hr3772ih.pdf |